RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers

Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers

15th Nov 2006, 12:30 GMT

Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague.

View full story at www.sciencedaily.com

Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers related news:

Latest news from ScienceDaily Headlines: